• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » BREAKING: Zimmer Biomet to spin off spine and dental businesses

BREAKING: Zimmer Biomet to spin off spine and dental businesses

February 5, 2021 By Chris Newmarker

Zimmer Biomet logoZimmer Biomet (NYSE:ZBH) — one of the world’s largest orthopedic device companies — will be a bit smaller going forward.

The Warsaw, Ind.–based company announced today that it will spin off its spine and dental businesses into a new, independent, publicly-traded company called NewCo. Zimmer Biomet plans to complete the transaction by mid-2022.

The businesses that fall under the NewCo banner made up nearly 13% of Zimmer Biomet revenues over the past two years, bringing in $1.022 billion in 2019 and $897 million in 2020. Differentiated spine products to help power NewCo’s growth include the Rosa One Spine robotic surgery system, the Mobi-C cervical disc and The Tether. Dental boasts a whole suite of oral reconstruction products.

Zimmer Biomet has been in the midst of a major reorganization in recent years as CEO Bryan Hanson seeks to refocus the businesses, with the company even recently announcing Medtronic veteran Ellie Humphrey’s hiring as its first chief transformation officer.

Spinning off the spine and dental businesses will allow the two companies to better focus on efficiency and leading their respective spaces, company officials said.

“This transaction will position us to prioritize resources, simplify our operating models and deliver greater value through two independent publicly traded companies,” Hanson said in a news release.

Senior research analyst Richard Newitter at SVB Leerink was positive on the news. “With the right leadership and management team executing — which we think Zimmer Biomet has in place — this is going to yield increased shareholder returns and create value better than otherwise would have been possible,” Newitter said in an interview with MassDevice. (We’ll have more quotes from Newitter in our latest DeviceTalks Weekly podcast.)

For Zimmer Biomet, the spinoff will be accretive to revenue growth by approximately 0.5% over the course of the company’s five-year strategic planning period, accelerate adjusted earnings per share growth and boost operating margins, according to the company.

Hanson will continue as Zimmer Biomet CEO; a NewCo CEO search is in its final stages. Zimmer Biomet said it will announce a NewCo board of directors, management and headquarters as it wraps up arrangements.

Completing the spinoff depends on final Zimmer Biomet board approval, receipt of a favorable opinion and Internal Revenue Service ruling over the transaction’s tax-free nature, and the effectiveness of a Form 10 registration statement that Zimmer Biomet will file with the U.S. Securities and Exchange Commission.

ZBH shares were down –0.62%, to $159.76, by the close of trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up 0.6%.

Beating expectations in Q4

News of the planned spinoff came on the same day that Zimmer Biomet announced Street-beating Q4 results.

Zimmer Biomet posted profits of $333.7 million, or $1.59 per share, off $2.085 billion in sales for the quarter ended Dec. 31, 2020, for a bottom-line gain of 4.1% on a top-line cut of –1.9% compared with Q4 2019.

Adjusted to exclude one-time items, earnings per share were $2.11, a nickel ahead of The Street, where analysts were looking EPS of $2.06 on sales of $2.08 billion.

Zimmer Biomet is still holding off on releasing financial guidance for 2021, citing uncertainty related to the COVID-19 pandemic — a position more common for small-cap companies. (Stryker, for example, has released 2021 guidance.)

“The fourth quarter saw continued pressure from COVID and its impact on the recovery of elective procedures, yet our core business remained strong as did our operational execution to close out 2020,” Hanson said. “Against that backdrop, we continue the transformation of our business in order to drive growth and increase shareholder value.”

On top of the Spine and Dental spinoff, Newitter at SVB Leerink is also positive about the increased share Zimmer Biomet is grabbing in the knee replacement space through its Persona Revision knee system that offers a more personalized fit, a wide variety of cementless knee technologies, and the Rosa surgical robotic system that allows ZB to compete with Stryker’s popular Mako robots.

Newitter is excited to see Zimmer Biomet launch its Persona IQ smart knee implant later this year. Created in collaboration with Canary Medical, Persona IQ will be able to track how a knee implant is performing inside a person in real-time.

Hanson during today’s earnings call described the Persona IQ has an important piece of the puzzle when it comes to creating a digital ecosystem around ZB’s implants.

Hanson said: “We’ve had a significant shift in our research and development dollars towards robotic storage, data informatics to build that ecosystem that’s going to be meaningful for patients and for our customers alike. And I got to say, there’s a lot of excitement around that in our organization, a lot of excitement from our customer base as well.”

 

 

Filed Under: Business/Financial News, Dental, Featured, Funding Roundup, Mergers & Acquisitions, Metal-on-Metal, News Well, Orthopedics, Spine Tagged With: Newco, Stryker, Zimmer Biomet

In case you missed it

  • DTW Podcast: Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently
  • ReWalk Robotics closes $40M private placement
  • Fusion Robotics wins FDA clearance for 3D imaging robotic targeting system
  • FDA authorizes Q-Collar to help protect athletes’ brains
  • The top 7 medtech CEO quotes on COVID-19, one year later
  • Forest Devices touts study of stroke detection tech
  • iRhythm’s revenue jumps 33% in Q4
  • Thermo Fisher completes Mesa Biotech acquisition
  • ICU Medical dips despite Street-beating Q4
  • Silk Road Medical touts results of large TCAR study
  • Pfizer wins FDA nod to store COVID vaccine at normal freezer temps
  • 8 drug delivery innovations you need to know
  • Terumo to acquire Health Outcomes Sciences
  • Axonics acquires Contura and its Bulkamid bulking agent for $235M
  • NuVasive reports mixed Q4 results
  • Is J&J’s COVID-19 vaccine linked to tinnitus?
  • UK passes post-Brexit medical device regulation

RSS From Medical Design & Outsourcing

  • FDA authorizes Q-Collar to help protect athletes’ brains
    The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for protecting the brain during sports activities. Q30 Sports Science’s Q-Collar is a C-shaped collar worn around the neck designed to apply compressive force to the neck and increase blood volume to help reduce movement of the brain within the cranial… […]
  • The top 7 medtech CEO quotes on COVID-19, one year later
    The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world… […]
  • Pfizer wins FDA nod to store COVID vaccine at normal freezer temps
    The FDA announced today that it is allowing undiluted, frozen vials of the Pfizer-BioNTech COVID-19 vaccine to be transported and stored for up to two weeks at conventional temperatures commonly found in pharmaceutical freezers. The decision should allow for wider distribution of the vaccine to sites that do not have ultra-low temperature freezers. Pfizer asked… […]
  • 8 drug delivery innovations you need to know
    The drug delivery space has seen plenty of innovation over the years, and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the… […]
  • Hoffer Plastics gains MedAccred certification again
    Injection molding company Hoffer Plastics (South Elgin, Ill.) announced that it has received the MedAccred re-certification from not-for-profit medtech audit provider MedAccred. MedAccred is a supply-chain oversight program of the Performance Review Institute. It conducts critical-process audits for its member OEMs to ensure their suppliers adhere to global regulations and requirements, and helps reduce the number… […]
  • UK passes post-Brexit medical device regulation
    The U.K. has enacted a new law governing medical devices and drugs, with a focus on patient safety. The Medicines and Medical Devices Act, introduced in July 2020, establishes the position of commissioner for patient safety to respond to public and patient complaints and concerns about drugs and medical devices. The law was necessitated by… […]
  • Integrated Polymer Solutions acquires IRP Group
    Integrated Polymer Solutions (“IPS”), a portfolio company of Arcline Investment Management, announced this week that it has acquired IRP Group. IRP designs and manufacturers elastomeric sealing components from its facilities in Southern California. Founded in 1999, the company is focused on the Class I and II medical device market as well as the aerospace &… […]
  • Interpower debuts plugs in new colors
    Interpower announced that its NEMA 5-20 hospital-grade plugs for use in North America now come in molded colors of clear, black or gray on 10-foot lengths of flexible cord. These molded plugs complement the company’s NEMA 5-20 hand-wired hospital-grade plugs. The North American 18A hospital-grade power cord on 14 AWG SJT cable and North American… […]
  • Portescap motors gain certification
    Portescap announced that its slotless brushless DC motors for respirators have received ISO 13485:2016 certification. Expanding on ISO 9001, this standard contains specific requirements for parts traceability and risk management activities throughout the design and development stages. It also requires process and software validations at defined intervals. Independent risk management and quality compliance firm DNV… […]
  • Instron launches update to product testing system
    Materials testing equipment and software developer Instron announced the launch of the Torsion Add-On 3.0 for universal testing systems. Recently redesigned to take advantage of the latest functionality offered by the new Instron 6800 series, this system offers a simpler, safer, and more intuitive user experience, according to Norwood, Mass.-based Instron. Instron introduced the Torsion… […]
  • Abiomed CEO Michael Minogue appointed as AdvaMed chairperson
    Medtech trade group AdvaMed today said it has appointed Abiomed (NSDQ:ABMD) president and CEO Michael Minogue as chairperson of the AdvaMed board of directors, effective immediately. Minogue will serve as chairperson of the trade association’s board of directors for two years. He has been a member of the board since 2007 and a member of the board… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS